BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grundy MK, Buckanovich RJ, Bernstein KA. Regulation and pharmacological targeting of RAD51 in cancer. NAR Cancer 2020;2:zcaa024. [PMID: 33015624 DOI: 10.1093/narcan/zcaa024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Kardell MB, Wang F, Wang L, Zhu S, Bessho T, Peng A. The Sm core components of small nuclear ribonucleoproteins promote homologous recombination repair. DNA Repair (Amst) 2021;108:103244. [PMID: 34768043 DOI: 10.1016/j.dnarep.2021.103244] [Reference Citation Analysis]
2 Wachholz V, Mustafa AM, Zeyn Y, Henninger SJ, Beyer M, Dzulko M, Piée-Staffa A, Brachetti C, Haehnel PS, Sellmer A, Mahboobi S, Kindler T, Brenner W, Nikolova T, Krämer OH. Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Arch Toxicol 2021. [PMID: 34665271 DOI: 10.1007/s00204-021-03174-1] [Reference Citation Analysis]
3 Takamatsu S, Brown JB, Yamaguchi K, Hamanishi J, Yamanoi K, Takaya H, Kaneyasu T, Mori S, Mandai M, Matsumura N. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. JCO Precis Oncol 2021;5:PO. [PMID: 34423229 DOI: 10.1200/PO.21.00141] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shkundina IS, Gall AA, Dick A, Cocklin S, Mazin AV. New RAD51 Inhibitors to Target Homologous Recombination in Human Cells. Genes (Basel) 2021;12:920. [PMID: 34208492 DOI: 10.3390/genes12060920] [Reference Citation Analysis]
5 Krasteva N, Staneva D, Vasileva B, Miloshev G, Georgieva M. Bioactivity of PEGylated Graphene Oxide Nanoparticles Combined with Near-Infrared Laser Irradiation Studied in Colorectal Carcinoma Cells. Nanomaterials (Basel) 2021;11:3061. [PMID: 34835825 DOI: 10.3390/nano11113061] [Reference Citation Analysis]
6 Demeyer A, Benhelli-Mokrani H, Chénais B, Weigel P, Fleury F. Inhibiting homologous recombination by targeting RAD51 protein. Biochim Biophys Acta Rev Cancer 2021;1876:188597. [PMID: 34332021 DOI: 10.1016/j.bbcan.2021.188597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Matos-Rodrigues G, Guirouilh-Barbat J, Martini E, Lopez BS. Homologous recombination, cancer and the 'RAD51 paradox'. NAR Cancer 2021;3:zcab016. [PMID: 34316706 DOI: 10.1093/narcan/zcab016] [Reference Citation Analysis]
8 Schürmann L, Schumacher L, Roquette K, Brozovic A, Fritz G. Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways. Cancer Lett 2021;520:361-73. [PMID: 34389435 DOI: 10.1016/j.canlet.2021.08.006] [Reference Citation Analysis]
9 Nguyen A, Dzulko M, Murr J, Yen Y, Schneider G, Krämer OH. Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion. Cells 2021;10:2520. [PMID: 34685500 DOI: 10.3390/cells10102520] [Reference Citation Analysis]
10 Wattenberg MM, Reiss KA. Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. Cancers (Basel) 2021;13:4716. [PMID: 34572943 DOI: 10.3390/cancers13184716] [Reference Citation Analysis]
11 Matos-Rodrigues G, Martini E, Lopez BS. Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis. Cancers (Basel) 2021;13:2083. [PMID: 33923105 DOI: 10.3390/cancers13092083] [Reference Citation Analysis]